CUBE vs KRYS · P/E 25, rev $1.07B vs P/E 46, rev $290.5M
CubeSmart (CUBE) versus Krystal Biotech Inc (KRYS) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported KRYS revenue for 2024-12-31 was $290.5M. Net income was $89.2M. Revenue was up 473.0% from 2023-12-31 to 2024-12-31. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Not investment advice. Open the CUBE and KRYS stock pages for the full models.
Not investment advice.